Cargando…
Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
Triple negative breast cancer (TNBC) cells are resistant to hormonal/targeted therapies. This study aims to investigate epigenetic differences between TNBC and other types of breast cancer and the effect of epigenetic modulation on the response of TNBC cells to hormonal therapy. Thus, we investigate...
Autores principales: | Ramadan, Wafaa S, Vazhappilly, Cijo George, Saleh, Ekram M, Menon, Varsha, AlAzawi, Aya M, El-Serafi, Ahmed T, Mansour, Wael, El-Awady, Raafat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356506/ https://www.ncbi.nlm.nih.gov/pubmed/30583472 http://dx.doi.org/10.3390/cancers11010013 |
Ejemplares similares
-
Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter?
por: Lozon, Lama, et al.
Publicado: (2022) -
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
por: Alseksek, Rahma K., et al.
Publicado: (2022) -
Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors
por: Madkour, Moustafa M., et al.
Publicado: (2023) -
The impact of CBP expression in estrogen receptor-positive breast cancer
por: Ramadan, Wafaa S., et al.
Publicado: (2021) -
Plant polyphenols can protect VEGF-induced vascular leakage?
por: Vazhappilly, Cijo George
Publicado: (2016)